Authors:
KAIREMO KJA
RAMSAY HA
PAAVONEN TK
JAASKELASAARI HA
TAGESSON M
LJUNGGREN K
STRAND SE
Citation: Kja. Kairemo et al., BIOKINETICS OF INDIUM-111-BLEOMYCIN COMPLEX IN HEAD AND NECK-CANCER -IMPLEMENTATIONS FOR RADIOCHEMOTHERAPY, Cancer detection and prevention, 21(1), 1997, pp. 83-90
Authors:
KAIREMO KJA
RAMSAY HA
TAGESSON M
JEKUNEN AP
PAAVONEN TK
JAASKELASAARI HA
LIEWENDAHL K
LJUNGGREN K
SAVOLAINEN S
STRAND SE
Citation: Kja. Kairemo et al., IN-111 BLEOMYCIN COMPLEX FOR RADIOCHEMOTHERAPY OF HEAD AND NECK-CANCER - DOSIMETRIC AND BIOKINETIC ASPECTS (VOL 23, PG 631, 1996), European journal of nuclear medicine, 24(2), 1997, pp. 235-235
Authors:
KAIREMO KJA
RAMSAY HA
TAGESSON M
JEKUNEN AP
PAAVONEN TK
JAASKELASAARI HA
LIEWENDAHL K
LJUNGGREN K
SAVOLAINEN S
STRAND SE
Citation: Kja. Kairemo et al., IN-111 BLEOMYCIN COMPLEX FOR RADIOCHEMOTHERAPY OF HEAD AND NECK-CANCER - DOSIMETRIC AND BIOKINETIC ASPECTS, European journal of nuclear medicine, 23(6), 1996, pp. 631-638
Citation: M. Tagesson et al., A MONTE-CARLO PROGRAM CONVERTING ACTIVITY DISTRIBUTIONS TO ABSORBED DOSE DISTRIBUTIONS IN A RADIONUCLIDE TREATMENT PLANNING SYSTEM, Acta oncologica, 35(3), 1996, pp. 367-372
Citation: M. Tagesson et al., TRANSFORMATION OF ACTIVITY DISTRIBUTION IN QUANTITATIVE SPECT TO ABSORBED DOSE DISTRIBUTION IN A RADIONUCLIDE TREATMENT PLANNING SYSTEM, The Journal of nuclear medicine, 35(5), 1994, pp. 160000123-160000123